Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership $13.95 +0.63 (+4.73%) (As of 03:04 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$12.03 M Get RCKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCKT Insider Buying and Selling by Quarter Ad ProsperityPubCrypto’s Hidden Gem: The missing piece no one’s talking aboutYou don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Rocket Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/21/2024Gaurav ShahCEOSell11,091$13.05$144,737.55 11/21/2024John MilitelloInsiderSell1,224$13.05$15,973.20 11/21/2024Martin WilsonGeneral CounselSell1,175$13.05$15,333.75 7/22/2024John MilitelloInsiderSell812$23.02$18,692.24 7/8/2024Mark Andrew WhiteInsiderSell3,026$20.39$61,700.14 5/16/2024Gaurav ShahCEOSell9,790$23.35$228,596.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/16/2024John MilitelloInsiderSell1,079$23.35$25,194.65 5/16/2024Martin WilsonGeneral CounselSell1,048$23.35$24,470.80 4/22/2024John MilitelloInsiderSell833$22.87$19,050.71 4/15/2024David P SouthwellDirectorSell10,000$24.05$240,500.00 4/12/2024David P SouthwellDirectorSell70,000$24.36$1,705,200.00 4/8/2024Mark Andrew WhiteInsiderSell12,532$24.64$308,788.48 3/21/2024Gotham MakkerDirectorSell274,000$28.43$7,789,820.00 3/21/2024John MilitelloInsiderSell2,490$28.10$69,969.00 2/29/2024John MilitelloInsiderSell10,000$29.84$298,400.00 2/29/2024Martin WilsonGeneral CounselSell4,100$29.33$120,253.00 2/16/2024Gaurav ShahCEOSell20,272$29.84$604,916.48 2/16/2024Kinnari PatelInsiderSell7,132$29.84$212,818.88 2/16/2024Martin WilsonGeneral CounselSell3,576$29.84$106,707.84 1/22/2024John MilitelloInsiderSell638$27.20$17,353.60 (Data available from 1/1/2013 forward) RCKT Insider Trading Activity - Frequently Asked Questions Who is on Rocket Pharmaceuticals's Insider Roster? The list of insiders at Rocket Pharmaceuticals includes David P Southwell, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT. What percentage of Rocket Pharmaceuticals stock is owned by insiders? 28.50% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings. Which Rocket Pharmaceuticals insiders have been selling company stock? The following insiders have sold RCKT shares in the last 24 months: David P Southwell ($1,945,700.00), Gaurav Shah ($1,284,413.66), Gotham Makker ($8,457,281.36), John Militello ($528,837.73), Jonathan David Schwartz ($67,796.42), Kinnari Patel ($236,549.86), Mark Andrew White ($370,488.62), and Martin Wilson ($266,765.39). How much insider selling is happening at Rocket Pharmaceuticals? Insiders have sold a total of 500,661 Rocket Pharmaceuticals shares in the last 24 months for a total of $13,157,833.04 sold. Rocket Pharmaceuticals Key ExecutivesMs. Kinnari Patel M.B.A. (Age 44)Pharm.D., Head of R&D, President & COO Compensation: $849.93kMr. Mayo Pujols (Age 54)Chief Technical Officer Compensation: $649.71kMr. Raj Prabhakar M.B.A. (Age 49)Chief Business Officer Compensation: $619.13kMr. Aaron Ondrey (Age 47)Chief Financial Officer Mr. Martin Louis Wilson J.D. (Age 48)General Counsel, Chief Compliance Officer & Chief Corporate Officer Compensation: $149.95kKevin GiordanoDirector of Corporate CommunicationsMs. Isabel Carmona J.D.Chief People OfficerMr. Jonathan Schwartz M.D. (Age 59)Chief Medical & Gene Therapy Officer Compensation: $557.79kDr. Gayatri R. Rao J.D.M.D., Senior VP of Clinical Safety & Chief Regulatory OfficerMr. Carlos MartinChief Commercial Operations & Revenue Officer More Insider Trading Tools from MarketBeat Related Companies Arcellx Insider Ownership BridgeBio Pharma Insider Ownership Avidity Biosciences Insider Ownership ADMA Biologics Insider Ownership Biohaven Insider Ownership Ultragenyx Pharmaceutical Insider Ownership Apellis Pharmaceuticals Insider Ownership Immunovant Insider Ownership Organon & Co. Insider Ownership PTC Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap Stocks This page (NASDAQ:RCKT) was last updated on 12/6/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredThis Company is Helping Brands Go Digital with Innovative Solutions.The growth of social media, e-Commerce, AI adoption and digital transformation has created an enormous window ...Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts